Enterprise Value

1.92B

Cash

480.6M

Avg Qtr Burn

-118M

Short % of Float

32.42%

Insider Ownership

4.99%

Institutional Own.

58.30%

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Update

Approved

Update

Approved

Update

Phase 3

Update

Phase 3

Initiation

Phase 2

Initiation

RSV Vaccine Details
Respiratory syncytial virus

Failed

Discontinued

RSV Vaccine Details
Respiratory syncytial virus

Failed

Discontinued

RSV Vaccine Details
Respiratory syncytial virus

Failed

Discontinued